Macular Degeneration Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with an inherited retinal disease (a genetic condition affecting the retina in the back of your eye)
- You are between 18 and 80 years old
- You have had genetic testing that clearly confirmed your inherited retinal disease
- You are male or female
- You have swelling in the central part of your retina (called macular oedema), confirmed by a scan, and this swelling has not reduced by more than 20% after at least 3 months of water-reducing treatments, or at least 4 months after your last eye injection
- The thickness of your central retina is above a certain measurement — over 320 microns if you are male, or over 305 microns if you are female (your eye doctor can check this)
- You still have your natural lens OR you have had it replaced with an artificial one
- You are willing and able to give your informed consent before the study begins
- You are able to understand the study instructions and are likely to attend all required appointments and complete all procedures
Who may not be able to join:
- You had cataract surgery less than 6 months ago
- Your eye pressure is too high (20 mmHg or above)
- Your retinal condition has not been confirmed by genetic testing
- You have diabetes
- You have certain other eye conditions, such as central serous chorioretinopathy, a blocked retinal vein, or age-related macular degeneration
- You currently have or have previously had other problems with the jelly-like substance inside your eye (vitreous) or the retina, or you have been advised to have surgery on this part of your eye
- You are unable to focus your vision on a target at a distance of 32 cm (confirm with trial site)
- You are pregnant
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Lucia Ziccardi, MD, PhD, IRCCS Fondazione G.B. Bietti
Phone: +390684009486
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
assessment of significative change in retinal oedema compared to baseline
Can't join this trial?
Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.